The New Congress and Pharmacy Benefit Manager Reform: Will the Insurers Escape Again?
The Senior Care Pharmacist · 2023
DOI: 10.4140/tcp.n.2023.70 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Senior Care Pharmacist, 2023. Verfasst von Paul Baldwin. Beteiligte Einrichtung: Baldwin Health Policy Group LLC. Hauptthemen laut MEDLINE: Medicare, Pharmacy. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
The Pharmacy Benefit Management industry is one which seems to attract bipartisan scorn, similar to the pharmaceutical manufacturers. Despite widespread criticism for many years, the manufacturers were finally presented with a big setback with the passage of the Inflation Reduction Act, which included a provision to require price negotiation in Medicare for prescription drugs. The provision does not go into effect until 2026, giving manufacturers time to escape-if they are able.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Baldwin Health Policy Group LLC.
Zitieren
APA
Baldwin, P. (2023). The New Congress and Pharmacy Benefit Manager Reform: Will the Insurers Escape Again?. The Senior Care Pharmacist. https://doi.org/10.4140/tcp.n.2023.70
Vancouver
Baldwin P. The New Congress and Pharmacy Benefit Manager Reform: Will the Insurers Escape Again?. The Senior Care Pharmacist. 2023. doi:10.4140/tcp.n.2023.70
BibTeX
@article{Baldwin2023,
author = {Baldwin, Paul},
title = {The New Congress and Pharmacy Benefit Manager Reform: Will the Insurers Escape Again?},
journal = {The Senior Care Pharmacist},
year = {2023},
doi = {10.4140/tcp.n.2023.70}
}
EUVIMED